Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its newly renamed 2025 Sustainability Report, highlighting the company's progress and refreshed approach to advancing a sustainable and responsible business model. “As we shape Baxter's next chapter, our focus remains clear: making a meaningful difference for patients, customers and communities while working to create long‑term value for all stakeholders,” said Andrew Hider, presiden.

Business Wire • Jun 22, 2026

Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform

BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.

Zacks Investment Research • Jun 19, 2026

Reasons to Retain Baxter International Stock in Your Portfolio for Now

BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.

Zacks Investment Research • Jun 16, 2026

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seeking Alpha • Jun 9, 2026

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

Earnings beats mean a lot more when it happens to stocks the market gave up on.

Market Watch • Jun 3, 2026

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 13, 2026

Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting

Baxter International NYSE: BAX held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the election of nine directors, executive compensation, auditor ratification, an amended incentive plan and a change related to board size.

MarketBeat • May 10, 2026

Baxter International Still Has A Path To Upside

In recent years, stocks like Baxter International have underperformed: most low-growth, high-debt, struggling names have been bad investments at basically any price. Concerns are real, and early missteps under new CEO Andrew Hider haven't helped. But valuation is attractive not just on an absolute basis but also relative to the outlook, and Q1 results seemed helpful to the bull case.

Seeking Alpha • May 8, 2026

Madison Small Cap Fund Q1 2026 Portfolio Activity

ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.

Seeking Alpha • May 5, 2026

Baxter beats quarterly expectations on strong demand for medical devices

Baxter on Thursday beat Wall Street estimates for first-quarter profit and revenue, helped by robust sales ​in its medical products and therapies unit.

Reuters • Apr 30, 2026